{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T20:42:19Z","timestamp":1705956139513},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:p>O v\u00edrus da hepatite C foi identificado em 1989 como sendo o principal agente causador das hepatites n\u00e3o-A n\u00e3o-B e o seu reconhecimento como agente de alta preval\u00eancia nas infec\u00e7\u00f5es p\u00f3s-tranfusionais e\/ou uso de derivados do sangue ou em associa\u00e7\u00e3o com o abuso de drogas endovenosas. A descoberta e a maior disponibilidade de novas t\u00e9cnicas para a sele\u00e7\u00e3o adequada de doadores de sangue, reduziu sensivelmente a incid\u00eancia das hepatites p\u00f3s-transfusionais. Cerca de 95% dos indiv\u00edduos infectados pelo v\u00edrus da hepatite C podem ser identificados pelos testes anti-v\u00edrus da hepatite C de terceira gera\u00e7\u00e3o. Os estudos retrospectivos de infec\u00e7\u00f5es pelo v\u00edrus da hepatite C iatrog\u00eanicas, s\u00e3o as principais fontes de reconhecimento da hist\u00f3ria natural da doen\u00e7a. A distribui\u00e7\u00e3o dos diferentes gen\u00f3tipos do v\u00edrus da hepatite C varia de acordo com as regi\u00f5es geogr\u00e1ficas. Na Am\u00e9rica do Sul, Europa, Estados Unidos e Jap\u00e3o 1, 2, e 3 representam a maioria das infec\u00e7\u00f5es, sendo o subtipo 1-b o mais prevalente. Os par\u00e2metros epidemiol\u00f3gicos (idade, fatores de risco e dura\u00e7\u00e3o da infec\u00e7\u00e3o) podem estar associados com os gen\u00f3tipos do v\u00edrus da hepatite C, sendo os tipos 1-a e 3-a mais freq\u00fcentes nos drogaditos endovenosos e o 1-b nas hepatites p\u00f3s-transfusionais. O subtipo 1-b ocasiona les\u00f5es hep\u00e1ticas mais graves e prolongadas, com altera\u00e7\u00f5es ultraestruturais mitocondriais freq\u00fcentes e grande comprometimento dos processos de fosforiliza\u00e7\u00e3o oxidativa. A produ\u00e7\u00e3o aumentada de radicais livres pode influenciar negativamente a evolu\u00e7\u00e3o da doen\u00e7a hep\u00e1tica pelo refor\u00e7o da a\u00e7\u00e3o citop\u00e1tica do v\u00edrus da hepatite C que provoca. O significado cl\u00ednico dos n\u00edveis de v\u00edrus C no interior do f\u00edgado, nesses pacientes, n\u00e3o \u00e9 determinado pelos fatores hospedeiro (idade, tipo e dura\u00e7\u00e3o da infec\u00e7\u00e3o) ou pelos fatores virais (gen\u00f3tipos) e os repetidamente v\u00edrus da hepatite C RNA RT-PCR negativos no soro, n\u00e3o indicam necessariamente aus\u00eancia de v\u00edrus da hepatite C no f\u00edgado. A associa\u00e7\u00e3o de autoimunidade \u00e0 hepatite C \u00e9 question\u00e1vel. Os marcadores imunes s\u00e3o freq\u00fcentemente detectados em baixos n\u00edveis. A modula\u00e7\u00e3o da resposta imune ao envelope prot\u00e9ico E2, ap\u00f3s inje\u00e7\u00e3o de plasm\u00eddios DNA, tem sido usada para induzir respostas imunes espec\u00edficas ao v\u00edrus da hepatite C. O espectro de tais respostas poderia ser ampliada mediante combina\u00e7\u00e3o de plasm\u00eddios, vias de administra\u00e7\u00e3o e outras formas de imun\u00f3genos codificados (vacinas a base de pept\u00eddios). Tais estrat\u00e9gias podem vir a ser importantes, em breve, no combate aos altamente mutantes v\u00edrus da hepatite C. O papel patog\u00eanico dos novos v\u00edrus G e TT das hepatites est\u00e1 em estudos, por\u00e9m \u00e9 de consenso que suas associa\u00e7\u00f5es com doen\u00e7a hep\u00e1tica ativa \u00e9 fortuita.<\/jats:p>","DOI":"10.1590\/s0004-28032000000300010","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T14:18:43Z","timestamp":1113574723000},"page":"187-193","source":"Crossref","is-referenced-by-count":3,"title":["Hepatite cr\u00f4nica por v\u00edrus C: Parte 1. Considera\u00e7\u00f5es gerais"],"prefix":"10.1590","volume":"37","author":[{"given":"Vin\u00edcio Paride","family":"CONTE","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.510280240","article-title":"Detection of widespread hepatocyte infection in chronic hepatitis C","volume":"28","author":"Agnello V","year":"1998","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref2","first-page":"85","article-title":"Estudo cl\u00ednico, laboratorial e histol\u00f3gico em doadores de sangue anti-HVC positivos","volume":"18","author":"Almeida PRL","year":"1999","journal-title":"GED Gastroenterol Endosc Dig"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","volume":"327","author":"Alter MJ","year":"1992","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/j.1572-0241.1999.01294.x","article-title":"Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings","volume":"94","author":"Barbaro G","year":"1999","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.42.4.456","article-title":"Is the hepatocyte a Troja horse for hepatitis C virus?","volume":"42","author":"Berenguer W","year":"1998","journal-title":"Gut","ISSN":"http:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C: MULTIVIRC Group. Multidepartment Virus C","volume":"42","author":"Cacoub P","year":"1999","journal-title":"Arthritis Rheum","ISSN":"http:\/\/id.crossref.org\/issn\/0004-3591","issn-type":"print"},{"key":"ref7","first-page":"19","article-title":"Les manifestations extra-h\u00e9patiques associ\u00e9es au virus de l'h\u00e9patite C (avant-propos)","volume":"151","author":"Cacoub P","year":"2000","journal-title":"Ann Med Interne (Paris)","ISSN":"http:\/\/id.crossref.org\/issn\/0003-410X","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a CDNA clone derived from a blood born non-A, non-B viral hepatitis genome","volume":"244","author":"Choo QL","year":"1989","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0035-9203(93)90269-V","article-title":"High level of hepatitis C endemicity in Gabon, equatorial Africa","volume":"87","author":"Delaporte E","year":"1993","journal-title":"Trans R Soc Trop Med Hyg","ISSN":"http:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(89)90485-6","article-title":"Hepatitis C virus antibodies among risk group in Spain","volume":"334","author":"Esteban JI","year":"1989","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.510280238","article-title":"Clinical outcome of hepatitis C as a function of mode of transmission","volume":"28","author":"Gordon SC","year":"1998","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/hep.1840180609","article-title":"The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs intravenous drug use","volume":"18","author":"Gordon SC","year":"1993","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/gut.42.4.570","article-title":"Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HVC infection","volume":"42","author":"Haydon GH","year":"1998","journal-title":"Gut","ISSN":"http:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1099\/0022-1317-75-7-1755","article-title":"Hepatitis V viral particle detected by immunoelectron microscopic study","volume":"75","author":"Hiranuma K","year":"1994","journal-title":"J Gen Virol","ISSN":"http:\/\/id.crossref.org\/issn\/0022-1317","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1099\/0022-1317-80-1-187","article-title":"Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus","volume":"80","author":"Hiranuma K","year":"1999","journal-title":"J Gen Virol","ISSN":"http:\/\/id.crossref.org\/issn\/0022-1317","issn-type":"print"},{"key":"ref16","first-page":"871","article-title":"Modes de transmission du virus de l'hepatite C","volume":"27","author":"Karmochkine M","year":"1998","journal-title":"Presse Med","ISSN":"http:\/\/id.crossref.org\/issn\/0032-7867","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"The Irish Hepatology Research Group: Clinical outcomes after hepatitis C infection from contamined anti-D immune globulin","volume":"340","author":"Kenny-Walsh E","year":"1999","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref18","first-page":"730","volume":"23","year":"1999","journal-title":"Gastroenterol Clin Biol","ISSN":"http:\/\/id.crossref.org\/issn\/0399-8320","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.271.5248.505","article-title":"Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent","volume":"271","author":"Linnen J","year":"1996","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0016-5085(89)90405-8","article-title":"Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection","volume":"97","author":"Martin P","year":"1989","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2893.1995.tb00071.x","article-title":"Hepatitis C virus infection in the asymptomatic British blood donor","volume":"2","author":"Mutimer DJ","year":"1995","journal-title":"Viral Hepat"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(98)04069-0","article-title":"Presence of a newly described human DNA virus (TTV) in patients with liver disease","volume":"352","author":"Naoumov NV","year":"1998","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/bbrc.1997.7765","article-title":"Novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology","volume":"241","author":"Nishizawa T","year":"1997","journal-title":"Biochem Biophys Res Comm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S0100-879X1999000300005","article-title":"Distribution of HVC genotypes among different exposure categories in Brazil","volume":"32","author":"Oliveira MLA","year":"1999","journal-title":"Braz J Med Biol Res","ISSN":"http:\/\/id.crossref.org\/issn\/0100-879X","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0140-6736(91)91094-B","article-title":"Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh","volume":"338","author":"Saeed AA","year":"1991","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199212313272703","article-title":"Long-term mortality after transfusion-associated non-A, non-B hepatitis","volume":"327","author":"Seef LB","year":"1992","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(98)03056-6","article-title":"Detection of a novel DNA virus (TTV) in blood donors and blood products","volume":"352","author":"Simmonds P","year":"1998","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref28","first-page":"166","article-title":"Crioglobulinemia mista e hepatite C: relato de quatro casos","volume":"19","author":"Strauss E","year":"2000","journal-title":"GED Gastroenterol Endosc Dig"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0168-8278(05)80657-9","article-title":"Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis","volume":"16","author":"Tremolada F","year":"1992","journal-title":"J Hepatol","ISSN":"http:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2893.1995.tb00070.x","article-title":"Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment","volume":"2","author":"Weltman MD","year":"1995","journal-title":"J Viral Hepat","ISSN":"http:\/\/id.crossref.org\/issn\/1352-0504","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1023\/A:1018824311722","article-title":"Hepatitis G and C viruses respond to interferon alfa with different virologic kinetics","volume":"43","author":"Yang G","year":"1998","journal-title":"Dig Dis Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0163-2116","issn-type":"print"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v37n3\/6621.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T22:24:51Z","timestamp":1495664691000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032000000300010&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0004-28032000000300010"],"URL":"https:\/\/doi.org\/10.1590\/s0004-28032000000300010","relation":{},"ISSN":["0004-2803"],"issn-type":[{"value":"0004-2803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}